Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Peters

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 29, 2008
Arrhythmogenic right ventricular dysplasia-cardiomyopathy and provocable coved-type ST-segment elevation in right precordial leads: clues from long-term follow-upStefan Peters
Journal of Clinical Medicine|November 4, 2020
Editorial: Cardiomyopathies: Current Treatment and Future OptionsStefan Peters
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 22, 2008
Comparison of efficacy of low- (80 mg/day) and high- (160-320 mg/day) dose valsartan in the prevention of in-stent restenosis after implantation of bare-metal stents in type B2/C coronary artery lesionsStefan Peters
International Journal of Cardiology|June 2, 2006
Advances in the diagnostic management of arrhythmogenic right ventricular dysplasia-cardiomyopathyStefan Peters
European Heart Journal. Acute Cardiovascular Care|September 25, 2013
QRS fragmentation in patients with arrhythmogenic right ventricular cardiomyopathy and complete right bundle branch block: a risk stratificationStefan Peters
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 15, 2007
Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centresStefan Peters
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Can angiotensin receptor antagonists prevent restenosis after stent placement?Stefan Peters
Journal of Atrial Fibrillation|December 3, 2016
Influence Of Novel Electrocardiographic Features Of Provocable Brugada ECG In Arrhythmogenic Cardiomyopathy And Its Exclusion By Lead AVRStefan Peters
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 24, 2008
Early repolarization phenomenon in arrhythmogenic right ventricular dysplasia-cardiomyopathy and sudden cardiac arrest due to ventricular fibrillationStefan Peters, Daniela Selbig
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|September 27, 2003
Diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy: value of standard ECG revisitedStefan Peters, Martina Trümmel
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 29, 2008
Arrhythmogenic right ventricular dysplasia-cardiomyopathy and provocable coved-type ST-segment elevation in right precordial leads: clues from long-term follow-upStefan Peters
Journal of Clinical Medicine|November 4, 2020
Editorial: Cardiomyopathies: Current Treatment and Future OptionsStefan Peters
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 22, 2008
Comparison of efficacy of low- (80 mg/day) and high- (160-320 mg/day) dose valsartan in the prevention of in-stent restenosis after implantation of bare-metal stents in type B2/C coronary artery lesionsStefan Peters
International Journal of Cardiology|June 2, 2006
Advances in the diagnostic management of arrhythmogenic right ventricular dysplasia-cardiomyopathyStefan Peters
European Heart Journal. Acute Cardiovascular Care|September 25, 2013
QRS fragmentation in patients with arrhythmogenic right ventricular cardiomyopathy and complete right bundle branch block: a risk stratificationStefan Peters
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 15, 2007
Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centresStefan Peters
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Can angiotensin receptor antagonists prevent restenosis after stent placement?Stefan Peters
Journal of Atrial Fibrillation|December 3, 2016
Influence Of Novel Electrocardiographic Features Of Provocable Brugada ECG In Arrhythmogenic Cardiomyopathy And Its Exclusion By Lead AVRStefan Peters
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 24, 2008
Early repolarization phenomenon in arrhythmogenic right ventricular dysplasia-cardiomyopathy and sudden cardiac arrest due to ventricular fibrillationStefan Peters, Daniela Selbig
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|September 27, 2003
Diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy: value of standard ECG revisitedStefan Peters, Martina Trümmel
Pageof 8